3/7/19 15:19 | 3/7/19 | AGN | Health | Drug | Pharmaceutical Preparations | Saunders Brent L | L2 | DO | CB,P,CEO | P | 253 | 143.67 | 0 | 2 | 1 | 171 | D | | | | | | | | | | | | | | |
11/19/18 19:22 | 11/16/18 | AGN | Health | Drug | Pharmaceutical Preparations | Walsh Matthew M | L2 | O | EVP,CFO | P | 157 | 157.00 | 0 | 1 | 4 | 26 | D | | | | | | | | | | | | | | |
9/7/18 08:31 | 9/6/18 | AGN | Health | Drug | Pharmaceutical Preparations | Coughlin Christopher J | | D | | P | 1,906 | 190.64 | 0 | 10 | 155 | 16 | D | | | | | | | | | | | | | | |
9/4/18 17:08 | 8/30/18 | AGN | Health | Drug | Pharmaceutical Preparations | Basgoz Nesli | | D | | S | -201 | 190.05 | 0 | -1 | -13 | 7 | D | | | | | | | | | | | | | | |
9/4/18 17:07 | 8/30/18 | AGN | Health | Drug | Pharmaceutical Preparations | Freyman Thomas C | L2 | D | | P | 210 | 190.69 | 0 | 1 | 71 | 3 | D | | | | | | | | | | | | | | |
9/4/18 17:06 | 8/30/18 | AGN | Health | Drug | Pharmaceutical Preparations | Boccuzi Joseph H | L2 | D | | P | 172 | 190.59 | 0 | 1 | 30 | 4 | D | | | | | | | | | | | | | | |
8/14/18 17:32 | 8/10/18 | AGN | Health | Drug | Pharmaceutical Preparations | Basgoz Nesli | | D | | M.d | 153 | 81.16 | 0 | 2 | 29 | 8 | D | | | | | | | | | | | | | | |
5/21/18 17:21 | 5/17/18 | AGN | Health | Drug | Pharmaceutical Preparations | Meury William | L2 | O | EVP,Chie | M.d | 1,447 | 68.11 | 0 | 21 | | 16 | D | | | | | | | | | | | | | | |
5/21/18 17:21 | 5/17/18 | AGN | Health | Drug | Pharmaceutical Preparations | Meury William | L2 | O | EVP,Chie | S.d | -3,776 | 154.59 | 0 | -24 | -61 | 16 | D | | | | | | | | | | | | | | |
3/19/18 09:36 | 3/15/18 | AGN | Health | Drug | Pharmaceutical Preparations | Hilado Maria Teresa | L2 | O | EVP | P | 150 | 167.39 | 0 | 1 | 3 | 27 | D | | | | | | | | | | | | | | |
3/9/18 16:31 | 3/5/18 | AGN | Health | Drug | Pharmaceutical Preparations | Boccuzi Joseph H | L2 | D | | P | 129 | 143.42 | 0 | 1 | 160 | 1 | D | | | | | | | | | | | | | | |
3/8/18 10:44 | 3/8/18 | AGN | Health | Drug | Pharmaceutical Preparations | Walsh Matthew M | L2 | O | EVP,CFO | P | 154 | 153.96 | 0 | 1 | 4 | 25 | D | | | | | | | | | | | | | | |
3/8/18 10:25 | 3/8/18 | AGN | Health | Drug | Pharmaceutical Preparations | Saunders Brent L | L2 | DO | CB,P,CEO | P | 503 | 152.53 | 0 | 3 | 2 | 181 | D | | | | | | | | | | | | | | |
2/22/18 16:25 | 2/21/18 | AGN | Health | Drug | Pharmaceutical Preparations | Walsh Matthew M | L2 | O | EVP,CFO | P.d | 322 | 160.94 | 0 | 2 | 9 | 24 | D | | | | | | | | | | | | | | |
2/16/18 17:10 | 2/14/18 | AGN | Health | Drug | Pharmaceutical Preparations | Meury William | L2 | O | Chief Co | M.d | 1,492 | 63.17 | 0 | 24 | 54 | 67 | D | | | | | | | | | | | | | | |
2/16/18 17:10 | 2/14/18 | AGN | Health | Drug | Pharmaceutical Preparations | Meury William | L2 | O | Chief Co | S.d | -9,457 | 160.62 | 0 | -59 | -47 | 67 | D | | | | | | | | | | | | | | |
12/7/17 17:21 | 12/7/17 | AGN | Health | Drug | Pharmaceutical Preparations | Bodine Chris W | L2 | D | | P | 499 | 164.77 | 0 | 3 | 22 | 17 | D | | | | | | | | | | | | | | |
12/6/17 12:31 | 12/6/17 | AGN | Health | Drug | Pharmaceutical Preparations | Saunders Brent L | L2 | DO | CB,P,CEO | P | 758 | 164.74 | 0 | 5 | 3 | 186 | D | | | | | | | | | | | | | | |
12/5/17 16:16 | 12/5/17 | AGN | Health | Drug | Pharmaceutical Preparations | Coughlin Christopher J | | D | | P | 1,633 | 163.30 | 0 | 10 | 225 | 14 | D | | | | | | | | | | | | | | |
12/4/17 18:21 | 12/1/17 | AGN | Health | Drug | Pharmaceutical Preparations | Meury William | L2 | O | Chief Co | M.d | 931 | 78.88 | 0 | 12 | 26 | 57 | D | | | | | | | | | | | | | | |
12/4/17 18:21 | 12/1/17 | AGN | Health | Drug | Pharmaceutical Preparations | Meury William | L2 | O | Chief Co | S.d | -2,053 | 173.89 | 0 | -12 | -17 | 57 | D | | | | | | | | | | | | | | |
10/30/17 21:41 | 10/26/17 | AGN | Health | Drug | Pharmaceutical Preparations | Bailey A Robert D | L2 | O | GC,Corp | M.d | 0 | 0.00 | 0 | 8 | 23 | 43 | D | | | | | | | | | | | | | | |
10/30/17 21:40 | 10/26/17 | AGN | Health | Drug | Pharmaceutical Preparations | Ling Karen | L2 | O | CHRO | M.d | 0 | 0.00 | 0 | 8 | 35 | 29 | D | | | | | | | | | | | | | | |
10/30/17 21:24 | 10/26/17 | AGN | Health | Drug | Pharmaceutical Preparations | Saunders Brent L | L2 | DO | CB,P,CEO | M.d | 0 | 0.00 | 0 | 51 | 39 | 182 | D | | | | | | | | | | | | | | |
10/30/17 21:24 | 10/26/17 | AGN | Health | Drug | Pharmaceutical Preparations | Meury William | L2 | O | Chief Co | M.d | 0 | 0.00 | 0 | 9 | 20 | 57 | D | | | | | | | | | | | | | | |
10/30/17 21:23 | 10/26/17 | AGN | Health | Drug | Pharmaceutical Preparations | Nicholson C. David | L2 | O | Chief R, | M.d | 0 | 0.00 | 0 | 6 | 48 | 19 | D | | | | | | | | | | | | | | |
10/30/17 21:22 | 10/26/17 | AGN | Health | Drug | Pharmaceutical Preparations | Stewart Robert A | L2 | O | COO | M.d | 0 | 0.00 | 0 | 12 | 22 | 69 | D | | | | | | | | | | | | | | |
10/30/17 21:20 | 10/26/17 | AGN | Health | Drug | Pharmaceutical Preparations | Hilado Maria Teresa | L2 | O | CFO | M.d | 0 | 0.00 | 0 | 7 | 36 | 27 | D | | | | | | | | | | | | | | |
10/30/17 21:19 | 10/26/17 | AGN | Health | Drug | Pharmaceutical Preparations | Darecca James | L2 | O | CHIEF AC | M.d | 0 | 0.00 | 0 | 1 | 23 | 4 | D | | | | | | | | | | | | | | |
10/30/17 21:19 | 10/26/17 | AGN | Health | Drug | Pharmaceutical Preparations | Bisaro Paul | L2 | D | | M.d | 0 | 0.00 | 0 | 38 | 11 | 392 | D | | | | | | | | | | | | | | |
9/18/17 20:49 | 3/29/17 | AGN | Health | Drug | Pharmaceutical Preparations | Saunders Brent L | L2 | DO | CB,P,CEO | P.m | 21 | 239.04 | 0 | 0 | 0 | 131 | D | | | | | | | | | | | | | | |
5/22/17 16:26 | 5/18/17 | AGN | Health | Drug | Pharmaceutical Preparations | Basgoz Nesli | | D | | M.d | 160 | 84.44 | 0 | 2 | 46 | 6 | D | | | | | | | | | | | | | | |
5/22/17 16:26 | 5/18/17 | AGN | Health | Drug | Pharmaceutical Preparations | Basgoz Nesli | | D | | S.d | -416 | 220.45 | 0 | -2 | -24 | 6 | D | | | | | | | | | | | | | | |
5/5/17 18:34 | 5/4/17 | AGN | Health | Drug | Pharmaceutical Preparations | Gallagher Michael R | L2 | D | | M.d | 4,339 | 245.25 | 33 | 18 | 122 | 32 | D | -14 | 15 | 18 | 7 | 4 | 3 | 3 | 0 | -1 | -6 | | | | |
3/6/17 06:59 | 3/2/17 | AGN | Health | Drug | Pharmaceutical Preparations | Bisaro Paul | L2 | D | | S | -17,268 | 246.68 | 33 | -70 | -16 | 356 | D | -17 | -15 | 5 | 27 | 15 | 0 | 0 | 0 | -1 | -2 | -3 | | | |
2/14/17 21:13 | 12/8/16 | AGN | Health | Drug | Pharmaceutical Preparations | Meury William | L2 | O | Chief Co | M.d | 1,288 | 109.12 | 33 | 12 | 43 | 39 | D | -12 | -12 | -1 | 14 | 17 | 16 | 8 | 2 | 0 | -1 | -3 | | | |
12/9/16 17:56 | 12/8/16 | AGN | Health | Drug | Pharmaceutical Preparations | Basgoz Nesli | | D | | S | -94 | 188.72 | 33 | -1 | -8 | 6 | D | -29 | -38 | -22 | -20 | -15 | -6 | -2 | -1 | -1 | 0 | 15 | 26 | | |
11/21/16 16:03 | 11/21/16 | AGN | Health | Drug | Pharmaceutical Preparations | Saunders Brent L | L2 | DO | CEO,P | P | 993 | 189.13 | 33 | 5 | 5 | 107 | D | -28 | -37 | -15 | -24 | -21 | -8 | -10 | -2 | -1 | -1 | 0 | 29 | | |
11/15/16 17:18 | 11/11/16 | AGN | Health | Drug | Pharmaceutical Preparations | Hilado Maria Teresa | L2 | O | CFO | P | 300 | 210.64 | 33 | 1 | 12 | 13 | D | -16 | -33 | -11 | -20 | -14 | -10 | 7 | -5 | 0 | -3 | -2 | 26 | | |
8/9/16 15:12 | 8/5/16 | AGN | Health | Drug | Pharmaceutical Preparations | Basgoz Nesli | | D | | M.d | 184 | 97.62 | 33 | 2 | 45 | 6 | D | 22 | -23 | -7 | 16 | 14 | 2 | -3 | -2 | 1 | 2 | -4 | -21 | -6 | |
8/9/16 15:12 | 8/5/16 | AGN | Health | Drug | Pharmaceutical Preparations | Basgoz Nesli | | D | | S.d | -192 | 253.02 | 33 | -1 | -11 | 6 | D | 22 | -23 | -7 | 16 | 14 | 2 | -3 | -2 | 1 | 2 | -4 | -21 | -6 | |
6/6/16 17:32 | 6/2/16 | AGN | Health | Drug | Pharmaceutical Preparations | Hilado Maria Teresa | L2 | O | CFO | P | 160 | 241.57 | 33 | 1 | 6 | 12 | D | 17 | -19 | -22 | -14 | 8 | 11 | 8 | 5 | 1 | -3 | -5 | -4 | -23 | |
5/12/16 19:39 | 5/11/16 | AGN | Health | Drug | Pharmaceutical Preparations | Basgoz Nesli | | D | | M.d | 38 | 82.53 | 33 | 0 | 11 | 5 | D | 10 | -25 | -25 | -20 | -17 | -2 | 2 | 10 | 3 | 6 | 11 | 16 | -9 | |
5/12/16 19:39 | 5/11/16 | AGN | Health | Drug | Pharmaceutical Preparations | Basgoz Nesli | | D | | S.d | -103 | 225.10 | 33 | 0 | -9 | 5 | D | 10 | -25 | -25 | -20 | -17 | -2 | 2 | 10 | 3 | 6 | 11 | 16 | -9 | |
12/9/15 16:26 | 12/7/15 | AGN | Health | Drug | Pharmaceutical Preparations | Basgoz Nesli | | D | | M.d | 190 | 82.53 | 33 | 2 | 131 | 4 | D | 86 | 17 | 3 | 5 | 9 | 4 | -3 | -1 | 0 | -1 | -2 | -6 | -19 | -38 |
12/9/15 16:26 | 12/7/15 | AGN | Health | Drug | Pharmaceutical Preparations | Basgoz Nesli | | D | | S.d | -720 | 312.96 | 33 | -2 | -36 | 4 | D | 86 | 17 | 3 | 5 | 9 | 4 | -3 | -1 | 0 | -1 | -2 | -6 | -19 | -38 |
8/24/15 18:29 | 8/21/15 | AGN | Health | Drug | Pharmaceutical Preparations | Saunders Brent L | L2 | DO | CEO,P | P | 302 | 301.94 | 33 | 1 | 1 | 133 | D | 124 | 32 | 2 | -1 | -6 | -11 | -5 | -7 | -1 | 5 | -2 | 3 | -2 | -13 |
8/24/15 18:28 | 8/24/15 | AGN | Health | Drug | Pharmaceutical Preparations | Bisaro Paul | L2 | DO | Exec CB | P | 297 | 297.42 | 33 | 1 | 0 | 422 | D | 124 | 32 | 2 | -1 | -6 | -11 | -5 | -7 | -1 | 5 | -2 | 3 | -2 | -13 |
6/10/15 16:28 | 6/9/15 | ACT | Health | Drug | Pharmaceutical Preparations | Basgoz Nesli | | D | | M.d | 182 | 82.53 | 0 | 2 | 105 | 4 | D | | | | | | | | | | | | | | |
6/10/15 16:28 | 6/9/15 | ACT | Health | Drug | Pharmaceutical Preparations | Basgoz Nesli | | D | | S.d | -655 | 297.89 | 0 | -2 | -34 | 4 | D | | | | | | | | | | | | | | |
12/1/14 17:15 | 11/26/14 | ACT | Health | Drug | Pharmaceutical Preparations | Meury William | L2 | O | See Rema | M.d | 638 | 90.06 | 0 | 7 | 9 | 82 | D | | | | | | | | | | | | | | |
12/1/14 17:15 | 11/26/14 | ACT | Health | Drug | Pharmaceutical Preparations | Meury William | L2 | O | See Rema | S.d | -1,225 | 269.14 | 0 | -5 | -5 | 82 | D | | | | | | | | | | | | | | |
9/10/14 17:13 | 9/8/14 | ACT | Health | Drug | Pharmaceutical Preparations | Paonessa Albert III | L2 | O | P Anda,I | S | -1,531 | 230.49 | 0 | -7 | -23 | 22 | D | | | | | | | | | | | | | | |
12/16/13 17:17 | 12/13/13 | ACT | Health | Drug | Pharmaceutical Preparations | Bodine Chris W | L2 | D | | S | -479 | 159.67 | 0 | -3 | -21 | 12 | D | | | | | | | | | | | | | | |
12/10/13 16:55 | 12/9/13 | ACT | Health | Drug | Pharmaceutical Preparations | Stewart Robert A | L2 | O | P-Global | S | -1,328 | 166.02 | 0 | -8 | -16 | 41 | D | | | | | | | | | | | | | | |
12/9/13 16:32 | 12/5/13 | ACT | Health | Drug | Pharmaceutical Preparations | Turner Andrew L | L2 | D | | S | -43 | 162.43 | 0 | 0 | -100 | 0 | D | | | | | | | | | | | | | | |
12/6/13 16:15 | 12/6/13 | ACT | Health | Drug | Pharmaceutical Preparations | Joyce R Todd | L2 | O | CFO-Glob | S | -2,421 | 165.83 | 0 | -15 | -27 | 40 | I | | | | | | | | | | | | | | |
12/4/13 17:42 | 12/2/13 | ACT | Health | Drug | Pharmaceutical Preparations | Taylor Ronald R | L2 | D | | S | -978 | 163.01 | 0 | -6 | -21 | 22 | D | | | | | | | | | | | | | | |
12/2/13 18:09 | 11/27/13 | ACT | Health | Drug | Pharmaceutical Preparations | Wilkinson George Fred | L2 | O | PRES-ACT | S | -3,996 | 165.00 | 0 | -24 | -61 | 15 | D | | | | | | | | | | | | | | |
11/27/13 17:10 | 11/26/13 | ACT | Health | Drug | Pharmaceutical Preparations | Mayr Charles M | L2 | O | Chief Co | S | -1,626 | 162.60 | 0 | -10 | -47 | 11 | D | | | | | | | | | | | | | | |
11/26/13 17:42 | 11/22/13 | ACT | Health | Drug | Pharmaceutical Preparations | Turner Andrew L | L2 | D | | S | -409 | 163.45 | 0 | -3 | -90 | 0 | D | | | | | | | | | | | | | | |
11/26/13 17:42 | 11/22/13 | ACT | Health | Drug | Pharmaceutical Preparations | Wilkinson George Fred | L2 | O | PRES-ACT | S.m | -954 | 165.00 | 0 | -6 | -13 | 40 | D | | | | | | | | | | | | | | |
11/19/13 17:35 | 11/15/13 | ACT | Health | Drug | Pharmaceutical Preparations | Stewart Robert A | L2 | O | P-Global | S | -1,644 | 164.44 | 0 | -10 | -17 | 49 | D | | | | | | | | | | | | | | |
11/18/13 16:30 | 11/14/13 | ACT | Health | Drug | Pharmaceutical Preparations | Weiss Fred G | L2 | D | | S | -492 | 164.15 | 0 | -3 | -11 | 24 | D | | | | | | | | | | | | | | |
11/13/13 20:19 | 11/11/13 | ACT | Health | Drug | Pharmaceutical Preparations | Bisaro Paul | L2 | DO | Chair,P, | S | -6,496 | 158.73 | 0 | -41 | -9 | 400 | D | | | | | | | | | | | | | | |
11/13/13 20:19 | 11/11/13 | ACT | Health | Drug | Pharmaceutical Preparations | Olafsson Sigurdur O | L2 | DO | P-ACTAVI | S | -3,997 | 159.87 | 0 | -25 | -26 | 72 | D | | | | | | | | | | | | | | |
11/13/13 18:36 | 11/11/13 | ACT | Health | Drug | Pharmaceutical Preparations | Buchen David A | L2 | O | GC-Globa | S | -4,779 | 159.30 | 0 | -30 | -33 | 60 | D | | | | | | | | | | | | | | |
11/13/13 18:36 | 11/11/13 | ACT | Health | Drug | Pharmaceutical Preparations | Stewart Robert A | L2 | O | P-Global | S | -1,901 | 158.39 | 0 | -12 | -17 | 59 | D | | | | | | | | | | | | | | |
11/13/13 18:35 | 11/11/13 | ACT | Health | Drug | Pharmaceutical Preparations | Paonessa Albert III | L2 | O | P Anda,I | S | -1,032 | 158.75 | 0 | -7 | -19 | 27 | D | | | | | | | | | | | | | | |
11/12/13 17:39 | 11/7/13 | ACT | Health | Drug | Pharmaceutical Preparations | King John A | L2 | D | | S.m | -24,625 | 155.92 | 0 | -158 | -71 | 65 | M | | | | | | | | | | | | | | |
11/8/13 16:09 | 11/6/13 | ACT | Health | Drug | Pharmaceutical Preparations | O'Sullivan Patrick J | L2 | D | | S | -551 | 157.34 | 0 | -4 | -61 | 2 | D | | | | | | | | | | | | | | |
11/8/13 16:09 | 11/6/13 | ACT | Health | Drug | Pharmaceutical Preparations | Howson Tamar D | L2 | D | | S | -47 | 157.34 | 0 | 0 | -24 | 1 | D | | | | | | | | | | | | | | |
11/8/13 16:08 | 11/6/13 | ACT | Health | Drug | Pharmaceutical Preparations | Ebert Charles D | L2 | O | SVP,BRAN | S | -1,727 | 158.75 | 0 | -11 | -59 | 8 | D | | | | | | | | | | | | | | |
11/7/13 16:16 | 11/5/13 | ACT | Health | Drug | Pharmaceutical Preparations | Joyce R Todd | L2 | O | CFO-Glob | S.m | -3,543 | 157.48 | 0 | -23 | -29 | 55 | I | | | | | | | | | | | | | | |
11/6/13 16:24 | 11/4/13 | ACT | Health | Drug | Pharmaceutical Preparations | Turner Andrew L | L2 | D | | S | -419 | 156.48 | 0 | -3 | -49 | 3 | D | | | | | | | | | | | | | | |
11/5/13 17:27 | 11/4/13 | ACT | Health | Drug | Pharmaceutical Preparations | Eagan Patrick | L2 | O | CHRO-GLO | S | -1,128 | 156.71 | 0 | -7 | -51 | 7 | D | | | | | | | | | | | | | | |